Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma
Authors
Keywords
-
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-30
DOI
10.1007/s10637-020-00945-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sacituzumab govitecan (IMMU-132) in patients with previously treated metastatic urothelial cancer (mUC): Results from a phase I/II study.
- (2019) Scott T. Tagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
- (2019) Jonathan E. Rosenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- EV-201: Results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and immune checkpoint inhibitors.
- (2019) Daniel Peter Petrylak et al. JOURNAL OF CLINICAL ONCOLOGY
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Phase 1 Trials of anti-ENPP3 antibody drug conjugates in advanced refractory renal cell carcinomas
- (2018) John A Thompson et al. CLINICAL CANCER RESEARCH
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non–Clear Cell Renal Cell Carcinomas: From Shadow to Light
- (2018) Laurence Albiges et al. JOURNAL OF CLINICAL ONCOLOGY
- Urinary kidney injury molecule-1 as an early diagnostic biomarker of obstructive acute kidney injury and development of a rapid detection method
- (2017) Yingli Jin et al. Molecular Medicine Reports
- Brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive haematologic malignancies and hepatic or renal impairment
- (2016) Baiteng Zhao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Kidney injury molecule-1 (KIM-1) mediates renal epithelial cell repair via ERK MAPK signaling pathway
- (2016) Zhiwei Zhang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Development of a Novel Antibody–Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1
- (2016) Lawrence J. Thomas et al. MOLECULAR CANCER THERAPEUTICS
- Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma
- (2015) M. Dror Michaelson et al. CANCER
- Kidney Injury Molecule-1 Enhances Endocytosis of Albumin in Renal Proximal Tubular Cells
- (2015) Xueying Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma
- (2014) Nizar M. Tannir et al. INVESTIGATIONAL NEW DRUGS
- T Cell Ig and Mucin Domain-1-Mediated T Cell Activation Requires Recruitment and Activation of Phosphoinositide 3-Kinase
- (2014) A. J. de Souza et al. JOURNAL OF IMMUNOLOGY
- Mechanisms of Epithelial Repair and Regeneration After Acute Kidney Injury
- (2014) Katja Berger et al. SEMINARS IN NEPHROLOGY
- A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802
- (2011) Naomi B. Haas et al. MEDICAL ONCOLOGY
- Rejection of the Kidney Allograft
- (2010) Brian J. Nankivell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more
- (2009) J. V. Bonventre NEPHROLOGY DIALYSIS TRANSPLANTATION
- The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model
- (2008) Takuya Ueno et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started